The first Jasper Therapeutics trade was made in Q1 2022.
Since then Jim Simons bought shares five more times and sold shares on three occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Jasper Therapeutics anymore.
Avg closing price
Price range
Sold -51.4k shares
Q1 2024
Avg closing price
$17.76
Price range
$6.63
-
$29.67
Increased shares by 65.8% (+20.4k shares)
Q4 2023
Avg closing price
$6.71
Price range
$4.24
-
$9.30
Increased shares by 433.9% (+25.2k shares)
Q3 2023
Avg closing price
$12.20
Price range
$6.77
-
$15.40
Sold 47.3% shares (-5.21k shares)
Q2 2023
Avg closing price
$14.86
Price range
$11.90
-
$17.90
Increased shares by 68.5% (+4.48k shares)
Q1 2023
Avg closing price
$18.48
Price range
$14.80
-
$27.40
Increased shares by 128.7% (+3.68k shares)
Q4 2022